In January 2018, the FDA announced a change requiring safety labeling to limit the use of prescription opioid cough and cold medicines containing Codeine or Hydrocodone in children younger than 18 years old due to the serious risks of these medicines outweigh the potential benefits.
Please see attachment for more information.